Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors

被引：28
|
作者：
Mahmood, Shams-ul [1 ]
Saeed, Aamer [1 ]
Bua, Sivia [2 ]
Nocentini, Alessio [2 ,3 ,4 ]
Gratteri, Paola [3 ,4 ]
Supuran, Claudiu T. [2 ]
机构：
[1] Quaid I Azam Univ, Dept Chem, Islamabad 45320, Pakistan
[2] Univ Florence, Dept NEUROFARBA, Pharmaceut & Nutraceut Sect, Via Ugo Schiff 6, I-50019 Florence, Italy
[3] Univ Florence, Dept NEUROFARBA, Sect Pharmaceut & Nutraceut Sci, Lab Mol Modeling Cheminformat,Pole Sci, Via U Schiff 6, I-50019 Florence, Italy
[4] Univ Florence, QSAR, Polo Sci, Via U Schiff 6, I-50019 Florence, Italy
来源：
BIOORGANIC CHEMISTRY | 2018年 / 77卷
关键词：
Carbonic anhydrase; Zinc-binding group; Nanomolar inhibition; Anti-glaucoma; Anti-tumour; ANTICANCER AGENTS; DESIGN; SULFONAMIDES; MOIETIES; DRUG; DERIVATIVES; ACTIVATORS; DISCOVERY; CANCER; BASES;
D O I：
10.1016/j.bioorg.2018.01.031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of iminothiazolidinone-sulfonamide hybrids (2a-k) was synthesized by heterocyclization of sulfanilamide thioureas with methyl bromoacetate and characterized by spectroscopic techniques, mass and elemental analysis. The synthesized derivatives were screened against four relevant human (h) isoforms of carbonic anydrases (CAs, EC 4.2.1.1) I, II, IV and IX. These enzymes are involved in a variety of diseases, including glaucoma, retinitis pigmentosa, epilepsy, arthritis, and tumors. Derivatives 2a-2k exhibited the best inhibitory activity against the cytosolyc hCA II (Kis are reaching the sub-nanomolar range, 0.41-37.8 nM) and against the tumor-associated isoform hCA IX (Kis are spanning between 24.3 and 368.3 nM). The binding mode of the reported iminothiazolidinone benzenesulfonamides within hCA II and IX catalytic clefts was investigated by docking studies. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：381 / 386
页数：6
相关论文
共 50 条
  • [1] Design, synthesis and biological evaluation of novel ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as potent carbonic anhydrase IX inhibitors
    Lolak, Nabih
    Akocak, Suleyman
    Bua, Silvia
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2019, 82 : 117 - 122
  • [2] Benzenesulfonamides bearing pyrrolidinone moiety as inhibitors of carbonic anhydrase IX: synthesis and binding studies
    Kęstutis Rutkauskas
    Asta Zubrienė
    Ingrida Tumosienė
    Kristina Kantminienė
    Vytautas Mickevičius
    Daumantas Matulis
    Medicinal Chemistry Research, 2017, 26 : 235 - 246
  • [3] Benzenesulfonamides bearing pyrrolidinone moiety as inhibitors of carbonic anhydrase IX: synthesis and binding studies
    Rutkauskas, Kestutis
    Zubriene, Asta
    Tumosienr, Ingrida
    Kantminiene, Kristina
    Mickevicius, Vytautas
    Matulis, Daumantas
    MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (01) : 235 - 246
  • [4] Design and synthesis of a series of novel heteroaryl benzenesulfonamides as carbonic anhydrase II inhibitors
    Cochran, Victoria
    Dao, August
    Gullett, Laura
    Hoballah, Jawad
    Narro, Efrain Castro
    Reeves, Mary-Grace
    Saganty, Ruth
    Siddall, Gemma
    Zinsli, Zach
    Scharf, Austin
    Spoering, Ryan
    Ranatunge, Ramani
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [5] New selective carbonic anhydrase IX inhibitors: Synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides
    Rogez-Florent, Tiphaine
    Meignan, Samuel
    Foulon, Catherine
    Six, Perrine
    Gros, Abigaelle
    Bal-Mahieu, Christine
    Supuran, Claudiu T.
    Scozzafava, Andrea
    Frederick, Raphael
    Masereel, Bernard
    Depreux, Patrick
    Lansiaux, Amelie
    Goossens, Jean-Francois
    Gluszok, Sebastien
    Goossens, Laurence
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (06) : 1451 - 1464
  • [6] Novel Diamide-Based Benzenesulfonamides as Selective Carbonic Anhydrase IX Inhibitors Endowed with Antitumor Activity: Synthesis, Biological Evaluation and In Silico Insights
    Abdelrahman, Mohamed A.
    Eldehna, Wagdy M.
    Nocentini, Alessio
    Bua, Silvia
    Al-Rashood, Sara T.
    Hassan, Ghada S.
    Bonardi, Alessandro
    Almehizia, Abdulrahman A.
    Alkahtani, Hamad M.
    Alharbi, Amal
    Gratteri, Paola
    Supuran, Claudiu T.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [7] Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors
    Yaseen, Raed
    Ekinci, Deniz
    Senturk, Murat
    Hameed, Alhamzah Dh
    Ovais, Syed
    Rathore, Pooja
    Samim, Mohammed
    Javed, Kalim
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (04) : 1337 - 1341
  • [8] Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies
    Elkamhawy, Ahmed
    Woo, Jiyu
    Nada, Hossam
    Angeli, Andrea
    Bedair, Tarek M.
    Supuran, Claudiu T.
    Lee, Kyeong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [9] Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Coumarinylthiazolyl Iminothiazolidinone Hybrids as Potent Urease Inhibitors
    Shams-Ul Mahmood
    Nazir, Yasir
    Saeed, Aamer
    Abbas, Qamar
    Ashraf, Zaman
    CHEMISTRYSELECT, 2020, 5 (18): : 5387 - 5390
  • [10] Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies
    Baglini, Emma
    Ravichandran, Rahul
    Berrino, Emanuela
    Salerno, Silvia
    Barresi, Elisabetta
    Marini, Anna Maria
    Viviano, Monica
    Castellano, Sabrina
    Da Settimo, Federico
    Supuran, Claudiu T.
    Cosconati, Sandro
    Taliani, Sabrina
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 1874 - 1883
12345